Sangamo Therapeutics
SGMO
SGMO
197 hedge funds and large institutions have $729M invested in Sangamo Therapeutics in 2018 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 52 increasing their positions, 77 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
197
Holders Change
-20
Holders Change %
-9.22%
% of All Funds
4.4%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
24
Increased
52
Reduced
77
Closed
42
Calls
$21.9M
Puts
$20.5M
Net Calls
+$1.34M
Net Calls Change
+$1.25M
Top Buyers
| 1 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$15.5M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$11.7M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$10.1M |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$9.67M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$8.03M |
Top Sellers
| 1 |
CC
Casdin Capital
New York
|
-$10.6M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$8.36M |
| 3 |
Millennium Management
New York
|
-$7.88M |
| 4 |
State Street
Boston,
Massachusetts
|
-$6.92M |
| 5 |
TAM
Tocqueville Asset Management
New York
|
-$6.8M |
